ArticleJournal of hepatocellular carcinoma2025
CT-Based 2.5D Deep Learning-Multi-Instance Learning for Predicting Early Recurrence of Hepatocellular Carcinoma and Correlating with Recurrence-Related Pathological Indicators.
Article in Journal of hepatocellular carcinoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of KRAS mutation in rectal cancer based on a 2.5D deep learning model.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims to evaluate the advantages of the 2.5D deep learning-multi-instance learning (2.5D DL-MIL) model, based on CT arterial phase images, in predicting early recurrence (ER) of hepatocellular carcinoma (HCC) and examining the biological significance of MIL features. Patients and Methods: A total of 191 HCC patients were retrospectively included and categorized into ER (n=79) and non-early recurrence (NER, n=112) groups based on postoperative follow-up results. The patients were randomly divided to the training set (n=133) and validation set (n=58) in a 7:3 ratio. The predictive capabilities of the 2.5D DL-MIL model, Radiomics model, and Clinical model for ER of HCC were constructed and compared using CT arterial phase and clinical data. SHAP analysis was used to evaluate the contribution of MIL features in the model, and further analysis was conducted on the correlation between MIL features and microvascular invasion (MVI), Ki-67 expression, and pathological grading. Results: The area under the curve (AUC) for the 2.5D DL-MIL model in the validation set was 0.840, surpassing that of the Radiomics model (AUC = 0.678, P = 0.047) and the Clinical model (AUC = 0.598, P = 0.009). Decision curve analyses indicated superior clinical utility for the 2.5D DL-MIL model. SHAP analysis revealed that bag-of-words features (eg, BoW_02 and BoW_09) were key contributors to the 2.5D DL-MIL model. Correlation analysis demonstrated that BoW_01, BoW_02, BoW_09, and BoW_1 were significantly correlated with MVI grade and Ki-67 expression (P < 0.05). Conclusion: The 2.5D DL-MIL model demonstrates significant value in predicting ER of HCC, with its MIL features exhibiting strong associations with tumor invasiveness and proliferative activity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.